Bath & Body Works (NYSE:BBWI) Given New $41.00 Price Target at JPMorgan Chase & Co.

Bath & Body Works (NYSE:BBWI) had its price target raised by JPMorgan Chase & Co. from $39.00 to $41.00 in a research note released on Friday,Benzinga reports. They currently have a neutral rating on the stock.

Several other equities research analysts also recently commented on BBWI. Piper Sandler upped their price objective on shares of Bath & Body Works from $36.00 to $39.00 and gave the company a “neutral” rating in a report on Monday, January 6th. Barclays increased their price target on shares of Bath & Body Works from $28.00 to $34.00 and gave the stock an “underweight” rating in a report on Tuesday, November 26th. Deutsche Bank Aktiengesellschaft increased their price target on shares of Bath & Body Works from $51.00 to $52.00 and gave the stock a “buy” rating in a report on Tuesday, November 26th. Wells Fargo & Company raised shares of Bath & Body Works from an “equal weight” rating to an “overweight” rating and increased their price target for the stock from $42.00 to $48.00 in a report on Friday, January 10th. Finally, Morgan Stanley lowered their price target on shares of Bath & Body Works from $51.00 to $48.00 and set an “overweight” rating on the stock in a report on Thursday, November 21st. One investment analyst has rated the stock with a sell rating, six have issued a hold rating and ten have assigned a buy rating to the stock. According to data from MarketBeat, Bath & Body Works currently has an average rating of “Moderate Buy” and a consensus target price of $43.19.

Bath & Body Works Stock Performance

Shares of NYSE:BBWI opened at $36.98 on Friday. The company’s 50-day moving average is $36.86 and its 200 day moving average is $33.66. The company has a market capitalization of $8.01 billion, a P/E ratio of 9.02, a price-to-earnings-growth ratio of 1.01 and a beta of 1.82. Bath & Body Works has a fifty-two week low of $26.20 and a fifty-two week high of $52.99.

Bath & Body Works (NYSE:BBWI) last released its quarterly earnings data on Monday, November 25th. The company reported $0.49 EPS for the quarter, beating the consensus estimate of $0.46 by $0.03. The business had revenue of $1.61 billion for the quarter, compared to the consensus estimate of $1.58 billion. Bath & Body Works had a net margin of 12.43% and a negative return on equity of 44.03%. The company’s revenue was up 3.1% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.48 earnings per share. As a group, research analysts predict that Bath & Body Works will post 3.26 earnings per share for the current year.

Bath & Body Works Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, December 6th. Shareholders of record on Friday, November 22nd were given a dividend of $0.20 per share. This represents a $0.80 dividend on an annualized basis and a yield of 2.16%. The ex-dividend date was Friday, November 22nd. Bath & Body Works’s payout ratio is currently 19.51%.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of BBWI. True Wealth Design LLC grew its position in Bath & Body Works by 5,270.0% during the third quarter. True Wealth Design LLC now owns 1,074 shares of the company’s stock valued at $34,000 after acquiring an additional 1,054 shares during the last quarter. UMB Bank n.a. grew its position in Bath & Body Works by 58.8% during the fourth quarter. UMB Bank n.a. now owns 905 shares of the company’s stock valued at $35,000 after acquiring an additional 335 shares during the last quarter. Livforsakringsbolaget Skandia Omsesidigt grew its position in Bath & Body Works by 300.0% during the third quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 1,200 shares of the company’s stock valued at $38,000 after acquiring an additional 900 shares during the last quarter. Wilmington Savings Fund Society FSB bought a new position in Bath & Body Works during the third quarter valued at approximately $39,000. Finally, TD Private Client Wealth LLC grew its position in Bath & Body Works by 24.2% during the third quarter. TD Private Client Wealth LLC now owns 1,697 shares of the company’s stock valued at $54,000 after acquiring an additional 331 shares during the last quarter. 95.14% of the stock is currently owned by institutional investors.

About Bath & Body Works

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.